In liver cancer (HCC), PRDX1 promotes cancer cell survival by reducing ROS accumulation and may exacerbate tumor progression by influencing immune evasion mechanisms (Hu et al., 2025). The gene discussed is PRDX1; the disease is hepatocellular carcinoma.